Clinical Trial Details
Braintumor Website

[Information provided by:, which provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.]

NCT02769806 : Advanced Perfusion MRI of Treatment Response and Progression in Glioblastoma
AgesMin: 18 Years Max: 82 Years
Inclusion Criteria:

- Histology: Glioblastoma (grade 4 astrocytoma)

- Standard-of-care, post-gd T1w image changes suggestive or consistent with of

- Standard-of-care MRI included conventional DSC-PWI without unexpected technical

- Methylation status of tumor available in medical record.

- Able to provide written informed consent.

Exclusion Criteria:

- Contraindications either to 3T MRI (e.g. certain metallic and electronic implants,
claustrophobia) or IV gadolinium contrast (allergy, pregnancy, breast-feeding, renal
insufficiency). Screening for these contraindications will be based on history only
(as it is for all routine outpatient clinical MRI at UWHC).

- Significant physical or mental disease which would preclude successful compliance and
participation in the study or, in the opinion of the principal investigator, or
co-investigator, constitute a hazard, such that enrollment in the study would not be
in the patient's best interest.

- Special subjects such as minors, mentally disabled persons, or prisoners.
LinksPermanent Link to THIS page:      |      Link to official listing

Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2020 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557